Hyogo, Japan – February 27, 2025 – JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) announced today that its Board of Directors resolved at a meeting held today to change in duties of corporate officers, organizational and personnel changes.
Download PDF below to read full announcement.